The chemokine CCL17 was significantly highly expressed in the ERS high-risk subgroup, whereas CCL28, CXCL12, and CXCL16 were expressed significantly less (Fig. 9B). This evidence concerns the gene CCL17 and amelogenesis imperfecta type 1G.